summary Pentraxin 3 (PTX3) is suggested to play important roles in the innate resistance against pathogens, regulation of in‰ammatory reactions, and clearance of apoptotic cells. PTX3 is theˆrst long pentraxin identiˆed. Long pentraxin shares a C-terminal pentraxin domain with the classical short pentraxin (C-reactive protein, serum amyloid P), but holds an unrelated N-terminal domain that is unique to the long pentraxin. While the short pentraxin is produced only in the liver, PTX3 is made by diverse types of cells, prominently endothelial cells and macrophage, in response to in‰ammatory signals. Unlike the short pentraxin, the expression of PTX3 in multiple types of tissue cells implies a mechanism for local ampliˆcation of innate resistance at the site of infection and in‰ammation. PTX3 plasma levels are very low in normal subjects but are rapidly increased by in‰ammatory conditions resulting from a wide range of diseased states, from infection to autoimmune and degenerative disorders. Critically ill patients show elevated circulating levels of PTX3 which are determined by the severity of the disease. Clinical evidence has demonstrated that the elevated PTX3 levels might be a useful early and sensitive marker for severely ill patients. Further studies will deˆnitely be needed to deepen our understanding of PTX3.
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